Ardea Biosciences, Inc. (RDEA) Misses Q1 Views
- Dollar General (DG) Reports In-Line Q2 EPS
- Signet Jewelers (SIG) Tops Q2 EPS by 1c; Updates FY15 EPS Outlook
- Market Wrap: Apple Loses Ban Appeal vs Samsung; Alibaba Reports Improved Profit; Tiffany Shines in Q2
- After-Hours Stock Movers 8/27: (CREG) (CCUR) (FEYE) Higher; (GOMO) (WSM) (GES) Lower (more...)
- Guess?, Inc. (GES) Misses Q2 EPS by 3c; Cuts FY15 Outlook
Ardea Biosciences, Inc. (Nasdaq: RDEA) reported Q1 EPS of ($0.59), $0.09 worse than the analyst estimate of ($0.50). Revenue for the quarter came in at $1.77 million versus the consensus estimate of $3.86 million.
You May Also Be Interested In
- Lannett (LCI) Tops Q4 EPS by 10c; Guides FY15 Revs Above Expectations
- Pall Corp. (PLL) Tops Q4 EPS by 5c; Guides FY15 EPS
- Tilly's (TLYS) Reports In-Line Q2 EPS, Offers Q3 Guidance
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!